KATY, TX / ACCESSWIRE / December 18, 2020 / Neutra Corporation (OTC PINK:NTRR) has enjoyed a year of important milestones and achievements that have set up the company for a strong 2021. These accomplishments are even more impressive considering the world saw the onset of a global pandemic in March that continues to this day.
Among the biggest highlights for 2020 include:
“It’s obviously been a year of great challenges because of COVID, but thanks to careful planning and a lot of hard work, Neutra is wrapping up its most successful year to date,” said CEO Sydney Jim. “I’m proud to inform our valued shareholders that we’ve met our goals for the year and we’re aiming much higher for 2021. We’re in a great position to accomplish even greater things in the coming 12 months in no small part due to our past success.”
One of the items that will help Neutra get off to a good start next is a new pain cream to be produced by its VIVIS subsidiary. This pain cream will deliver superior relief for users through a broad spectrum CBD dosage of 1000 mg. The market potential for this pain cream is vast as more than 116 million Americans suffer from chronic pain issues.
To learn more about these and other VIVIS hemp-based CBD products, visit the company’s website at http://viviscbd.com.
About Neutra Corp.
Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company’s website at http://www.NeutraInc.com.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Contact:
Sydney Jim
888-433-4033
info@neutrainc.com
SOURCE: Neutra Corp
View source version on accesswire.com:
https://www.accesswire.com/621525/Neutra-Poised-for-Greater-Growth-as-Another-Successful-Year-Comes-to-a-Close
MEMPHIS, Tenn., July 5, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare announced its four Memphis-based adult hospitals…
TEMPE, Ariz., July 5, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in June…
mCare Digital unveils the mCareWatch MW-241 powered by KORE connectivity ATLANTA, July 5, 2024 /PRNewswire/…
Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of…
Image acquisition and defocusing correction techniques enable observations of atomic-scale magnetic fields at never-before-seen resolution…
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical…